← Insider buys
KRTX

Karuna Therapeutics, Inc.

Director Atul Pande sold $425K of Karuna Therapeutics, Inc.

Sold$425,000
$85.00Price
5,000Shares
−100%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Wed, Aug 12. Filed Fri, Aug 14. Not investment advice.